Nordea Investment Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,810
| Closed | -$705K | – | 990 |
|
|
2022
Q3 | $705K | Hold |
2,810
| – | – | ﹤0.01% | 846 |
|
|
2022
Q2 | $701K | Buy |
2,810
+582
| +26% | +$145K | ﹤0.01% | 858 |
|
|
2022
Q1 | $736K | Sell |
2,228
-16,027
| -88% | -$5.29M | ﹤0.01% | 849 |
|
|
2021
Q4 | $6.58M | Sell |
18,255
-801
| -4% | -$289K | 0.01% | 527 |
|
|
2021
Q3 | $6.35M | Buy |
19,056
+48
| +0.3% | +$16K | 0.01% | 560 |
|
|
2021
Q2 | $5.93M | Sell |
19,008
-99
| -0.5% | -$30.9K | 0.01% | 575 |
|
|
2021
Q1 | $6.11M | Buy |
19,107
+657
| +4% | +$210K | 0.01% | 535 |
|
|
2020
Q4 | $5.98M | Buy |
18,450
+2,121
| +13% | +$688K | 0.01% | 491 |
|
|
2020
Q3 | $4.47M | Buy |
16,329
+8,133
| +99% | +$2.22M | 0.01% | 512 |
|
|
2020
Q2 | $1.96M | Buy |
8,196
+4,098
| +100% | +$982K | ﹤0.01% | 720 |
|
|
2020
Q1 | $611K | Sell |
4,098
-5
| -0.1% | -$745 | ﹤0.01% | 766 |
|
|
2019
Q4 | $701K | Buy |
4,103
+885
| +28% | +$151K | ﹤0.01% | 790 |
|
|
2019
Q3 | $562K | Buy |
3,218
+123
| +4% | +$21.5K | ﹤0.01% | 830 |
|
|
2019
Q2 | $807K | Buy |
3,095
+652
| +27% | +$170K | ﹤0.01% | 789 |
|
|
2019
Q1 | $696K | Buy |
2,443
+459
| +23% | +$131K | ﹤0.01% | 1035 |
|
|
2018
Q4 | $646K | Buy |
1,984
+69
| +4% | +$22.5K | ﹤0.01% | 1024 |
|
|
2018
Q3 | $861K | Hold |
1,915
| – | – | ﹤0.01% | 1026 |
|
|
2018
Q2 | $783K | Sell |
1,915
-8,845
| -82% | -$3.62M | ﹤0.01% | 871 |
|
|
2018
Q1 | $3.13M | Sell |
10,760
-2,127
| -17% | -$619K | 0.01% | 568 |
|
|
2017
Q4 | $2.42M | Sell |
12,887
-1,630
| -11% | -$305K | 0.01% | 639 |
|
|
2017
Q3 | $2.45M | Buy |
14,517
+502
| +4% | +$84.7K | 0.01% | 559 |
|
|
2017
Q2 | $2.01M | Sell |
14,015
-194
| -1% | -$27.8K | 0.01% | 588 |
|
|
2017
Q1 | $1.78M | Buy |
+14,209
| New | +$1.78M | ﹤0.01% | 583 |
|